Sort by
Items per page

Send to

Choose Destination

Links from Conserved Domains

Items: 6


TRIM59 is up-regulated in gastric tumors, promoting ubiquitination and degradation of p53.

Zhou Z, Ji Z, Wang Y, Li J, Cao H, Zhu HH, Gao WQ.

Gastroenterology. 2014 Nov;147(5):1043-54. doi: 10.1053/j.gastro.2014.07.021. Epub 2014 Jul 18.


TRIM59, a novel multiple cancer biomarker for immunohistochemical detection of tumorigenesis.

Khatamianfar V, Valiyeva F, Rennie PS, Lu WY, Yang BB, Bauman GS, Moussa M, Xuan JW.

BMJ Open. 2012 Oct 8;2(5). pii: e001410. doi: 10.1136/bmjopen-2012-001410. Print 2012.


A novel accessory molecule Trim59 involved in cytotoxicity of BCG-activated macrophages.

Zhao X, Liu Q, Du B, Li P, Cui Q, Han X, Du B, Yan D, Zhu X.

Mol Cells. 2012 Sep;34(3):263-70. Epub 2012 Sep 3.


TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7-mediated signal pathways.

Kondo T, Watanabe M, Hatakeyama S.

Biochem Biophys Res Commun. 2012 Jun 8;422(3):501-7. doi: 10.1016/j.bbrc.2012.05.028. Epub 2012 May 12.


Characterization of the oncogenic activity of the novel TRIM59 gene in mouse cancer models.

Valiyeva F, Jiang F, Elmaadawi A, Moussa M, Yee SP, Raptis L, Izawa JI, Yang BB, Greenberg NM, Wang F, Xuan JW.

Mol Cancer Ther. 2011 Jul;10(7):1229-40. doi: 10.1158/1535-7163.MCT-11-0077. Epub 2011 May 18.


Identification and characterization of a long isoform of human IFT80, IFT80-L.

Huang W, Kane JK, Li MD.

Biochem Biophys Res Commun. 2008 Sep 5;373(4):653-8. doi: 10.1016/j.bbrc.2008.06.085. Epub 2008 Jul 2.


Supplemental Content

Support Center